Sutro Biopharma to present updated corporate presentation at JMP conference

SUTRO BIOPHARMA, INC.

Corporate presentation attached as Exhibit 99.1, available on company website.
Presentation covers company overview as of June 2022; no financial or pipeline data disclosed in filing.
No material changes to business, guidance, or clinical programs announced in the 8-K.

item 8.01 item 9.01

SUTRO BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0000950170-22-011712

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.